Young researchers and Innovators call for online meeting on "Parasitology and biological evaluation for drug screening in One Health perspective"
Young researchers and Innovators call for online meeting on "Parasitology and biological evaluation for drug screening in One Health perspective"
Feb 19, 2026 17-18 CET
Dear All
Hope this email finds you well, with a good start to 2026.
Within the framework of the COST Action OneHealthDrugs (OHD, https://onehealthdrugs.com/), we have been organizing learning sessions since July 2025 as part of the Young Researchers Horizontal Group 4, focusing on various topics of interest for our COST Action. The first two sessions covered green chemistry and chemoinformatics, and we are now organizing one on "Parasitology and biological evaluation for drug screening within the One Health framework."
Given your experience and young age, we would be delighted to invite you to share a case study of your choice that you consider relevant and significant to the topic. This would involve an online presentation of around 20 minutes, followed by a brief Q&A session, is planned for February 19.
Confirmed speakers:
Estefania Calvo Alvarez, RTD University of Milan, Italy
Michela CERONE, Postdoctoral Research Associate. Imperial College London. PhD, Chemistry and Biochemistry, University of St Andrews
Elisa, leader of the Horizontal group 4 for YRI, OneHealthdrugs COST Action
COST
What is COST?
COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. The COST ACTIONS help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation.
OneHealthdrugs CA21111
Title:
One Health drugs against parasitic vector borne diseases in Europe and beyond